These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8428691)

  • 1. Studies on ras oncogene activation in endometrial carcinoma.
    Fujimoto I; Shimizu Y; Hirai Y; Chen JT; Teshima H; Hasumi K; Masubuchi K; Takahashi M
    Gynecol Oncol; 1993 Feb; 48(2):196-202. PubMed ID: 8428691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient.
    Ito K; Watanabe K; Nasim S; Sasano H; Sato S; Yajima A; Silverberg SG; Garrett CT
    Gynecol Oncol; 1996 Nov; 63(2):238-46. PubMed ID: 8910634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma.
    Duggan BD; Felix JC; Muderspach LI; Tsao JL; Shibata DK
    Cancer Res; 1994 Mar; 54(6):1604-7. PubMed ID: 8137266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
    Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
    Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the point mutation of ras oncogene in ovarian tumor].
    Fujimoto I; Shimizu Y; Umezawa S; Katase K; Hirai Y; Yamauchi K; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1289-96. PubMed ID: 8258728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras activation in neoplasms of the human female reproductive tract.
    Enomoto T; Inoue M; Perantoni AO; Terakawa N; Tanizawa O; Rice JM
    Cancer Res; 1990 Oct; 50(19):6139-45. PubMed ID: 2205377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of K-ras oncogene activation in human lung cancer and its possible clinical application].
    Zhang G; Sun Y; Wang M
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):282-4, 317. PubMed ID: 8762479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.
    Sugio K; Ishida T; Yokoyama H; Inoue T; Sugimachi K; Sasazuki T
    Cancer Res; 1992 May; 52(10):2903-6. PubMed ID: 1581907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium.
    Mizuuchi H; Nasim S; Kudo R; Silverberg SG; Greenhouse S; Garrett CT
    Cancer Res; 1992 May; 52(10):2777-81. PubMed ID: 1581890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.
    Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T
    Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the Ki-ras oncogene in carcinoma of the endometrium.
    Caduff RF; Johnston CM; Frank TS
    Am J Pathol; 1995 Jan; 146(1):182-8. PubMed ID: 7856726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of K-ras mutation from malignant cells in sputum with mutant-allele specific amplification (MASA) method].
    Kimura S; Fukuchi K; Takeda S; Shin S; Saito D; Akamatsu S; Himeji Y; Chen GL; Watanabe H; Takagi Y
    Rinsho Byori; 1995 Jul; 43(7):718-23. PubMed ID: 7674546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of c-Ki-ras oncogene codon 12 point mutations in lung carcinoma, gastric carcinoma and hepatic carcinoma].
    Cui Q; Wang Z; Chen J; Liu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Apr; 18(2):95-8. PubMed ID: 9208596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of G-T mutations at codon 12 of c-Ha-ras oncogenes in squamous cell carcinomas of the sinus maxillaris].
    Liu XF
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(6):345-7, 382. PubMed ID: 1303668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
    Inoue M
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma.
    Caduff RF; Johnston CM; Svoboda-Newman SM; Poy EL; Merajver SD; Frank TS
    Am J Pathol; 1996 May; 148(5):1671-8. PubMed ID: 8623934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.